Franck Le Deu

Franck Le Deu, a Senior Partner at McKinsey, and Ji Li, a former BD executive at major biopharmas, delve into the booming collaboration between Western and Chinese biotechs. They examine the surge in cross-border deals driven by China's maturing biotech ecosystem. The conversation reveals the Hong Kong Stock Exchange's role as a hotspot for biotech IPOs, shifting dynamics in deal-making, and the emergence of innovative companies in China. Insights on upcoming conferences and networking opportunities also highlight the future of global biopharma partnerships.

Experts discuss the shifts in China's economy and how multinationals can adapt their strategies. Topics include investments in China, challenges faced by new entrants, gender equality in Chinese workplaces, urbanization's impact on birth rates and healthcare, risks of China's high debt, decline of multinationals in China, and recommendations for success.